Lupin (LUPIN) — Announcement

Lupin Limited announced that its Netherlands subsidiary Nanomi will acquire 100% of VISUfarma B.V. for an enterprise value of €190 million in cash, financed from existing balance sheet reserves. VISUfarma, a pan-European specialty ophthalmology company with €48.1 million turnover (CY24) and ~60+ branded products, operates across Italy, UK, Spain, Germany, and France. The acquisition aligns with Lupin's strategy to expand its European presence and specialty franchise in ophthalmology. The deal is expected to close by end-2025, subject to regulatory approvals in Germany and notification in Spain, and is projected to be accretive to sales growth and EBITDA margins.

📄 View Original Announcement (PDF)

📊 Stock Analysis — LUPIN ✨ Ask AI About This

About Lupin Limited (LUPIN)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,04,071.47 Cr P/E: 36.2

View full LUPIN stock details →

📡 Get AI alerts when LUPIN files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track LUPIN — Free

💡 Ask AI about this filing

"How does this announcement affect Lupin Limited's outlook?" "What did Lupin Limited announce on 29 September 2025?" "Is this positive or negative for LUPIN?"

Ask AI Free →

📊 More LUPIN filings

See all LUPIN filings →

🔥 Also filed on 29 September 2025

TATAPOWER Tata Power Company Limited Offer Document BAJFINANCE Bajaj Finance Limited Corporate Action BHARTIARTL Bharti Airtel Limited Financial Results NHPC NHPC Limited Corporate Action OBEROIRLTY Oberoi Realty Limited Announcement POLYCAB Polycab India Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when LUPIN files new disclosures

Track LUPIN filings, board meetings, and corporate actions. Free email alerts at 5 PM.